wholevirusbas
immunofluoresc
assay
ifa
consid
one
sensit
assay
serv
gold
standard
sar
epidem
singapor
howev
need
manipul
live
sarscov
tradit
ifa
limit
wide
applic
due
requir
biosafeti
level
laboratori
risk
laboratori
infect
previous
identifi
two
immunodomin
epitop
name
sc
two
major
structur
protein
n
protein
sarscov
q
k
present
studi
fusion
protein
highli
express
insect
cell
infect
recombin
baculoviru
bear
hybrid
gene
control
polyhedrin
promot
ifa
base
cell
produc
fusion
protein
standard
serum
sampl
patient
sar
serum
sampl
patient
autoimmun
diseas
serum
sampl
healthi
blood
donor
detect
rate
compar
obtain
commerci
sarscov
ifa
kit
euroimmun
gross
groenau
germani
convent
ifa
perform
singapor
gener
hospit
data
show
newli
develop
ifa
could
detect
sarscov
sarscovposit
serum
sampl
gave
falseposit
result
sera
patient
autoimmun
diseas
healthi
individu
test
detect
rate
ident
two
wholevirusbas
ifa
thu
novel
ns
fusion
antigenbas
ifa
could
attract
altern
present
wholevirusbas
ifa
diagnosi
sarscov
infect
februari
physician
guangdong
provinc
peopl
republ
china
fell
ill
stay
hotel
hong
kong
later
respiratori
ill
spread
hotel
guest
subsequ
travel
countri
start
worldwid
epidem
diseas
come
known
sever
acut
respiratori
syndrom
sar
caus
coronaviru
call
sarsassoci
coronaviru
sarscov
scientist
around
world
respond
quickli
sar
outbreak
isol
novel
viru
develop
rapid
diagnost
method
earli
detect
sarscov
infect
method
current
avail
detect
sarscov
viru
isol
inocul
patient
biolog
sampl
cell
cultur
vero
cell
cultur
ii
nucleotid
sequenc
detect
pcr
revers
transcriptionpcr
rtpcr
stringent
laboratori
procedur
need
adher
avoid
cross
contamin
sampl
iii
antigen
detect
specif
monoclon
antibodi
sarscov
antigen
iv
antibodi
detect
viral
proteinand
virusinfect
cell
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
ifa
respect
howev
high
degre
pathogen
infect
human
antigen
product
elisa
ifa
requir
biosafeti
level
research
facil
product
involv
use
live
sarscov
restrict
make
difficult
prepar
diagnost
reagent
previou
work
identifi
major
immunodomin
fragment
nucleocapsid
spike
sc
protein
sarscov
recombin
proteinbas
western
blot
assay
show
high
antibodi
detect
rate
howev
method
laborintens
timeconsum
method
involv
protein
express
purif
present
ifa
regard
gold
standard
detect
sarscov
infect
howev
involv
hazard
work
viru
cultiv
laboratori
explor
sensit
assay
involv
manipul
live
sarscov
develop
ifa
use
spodoptera
frugiperda
insect
cell
line
recombin
baculoviru
express
fusion
protein
antigen
detect
antibodi
sarscov
fusion
proteinbas
ifa
techniqu
crossreact
coronavirusinfect
sera
found
specif
sensit
novel
ifa
assess
panel
serum
sampl
compris
serum
sampl
posit
sarscov
serum
sampl
patient
autoimmun
diseas
serum
sampl
healthi
individu
result
compar
obtain
two
wholevirusbas
ifa
commerci
sarscov
ifa
kit
euroimmun
gross
groenau
germani
convent
ifa
perform
laboratori
singapor
gener
hospit
well
western
blot
assay
serum
sampl
sera
collect
patient
day
onset
symptom
satisfi
world
health
organ
definit
sar
twenti
serum
sampl
patient
autoimmun
diseas
serum
sampl
healthi
individu
obtain
singapor
gener
hospit
tan
tock
seng
hospit
serum
sampl
heat
inactiv
h
use
four
serum
sampl
infecti
bronchiti
virusinfect
chicken
serum
sampl
transmiss
gastroenter
virusinfect
swine
canin
coronavirusvaccin
serum
sampl
dog
use
test
crossreact
ten
serum
sampl
stray
dog
serum
sampl
stray
cat
also
test
product
polyclon
antibodi
n
protein
spike
protein
sc
protein
express
purifi
describ
previou
report
guinea
pig
immun
purifi
sc
protein
concentr
g
booster
inject
administ
interv
ten
day
later
anim
euthan
serum
prepar
sampl
evalu
antibodi
sc
protein
sc
proteinbas
elisa
respect
commerci
sarscov
ifa
kit
inactiv
whole
sarscovinfect
vero
cell
pattern
reactiv
antisera
protein
observ
two
antisera
use
monitor
sc
protein
express
cell
infect
recombin
viru
contain
fusion
protein
western
blot
fusion
proteinbas
ifa
describ
construct
nucleocapsid
spike
protein
express
vector
viral
rna
extract
inactiv
viru
cultur
supernat
use
trizol
reagent
gibco
grand
island
ny
revers
transcrib
produc
cdna
cdna
use
templat
pcr
amplif
yield
truncat
sc
gene
fragment
use
primer
pair
list
tabl
amplifi
sc
dna
fragment
digest
ligat
respect
site
form
fusion
gene
fragment
follow
subclon
bamhikpni
site
pfastbacht
transform
escherichia
coli
compet
cell
presenc
result
recombin
transfer
plasmid
verifi
pcr
primer
tabl
sequenc
analysi
done
recombin
plasmid
dna
prepar
wizard
miniprep
kit
promega
homolog
recombin
carri
transposit
plasmid
dna
compet
cell
inocul
cell
onto
luria
agar
contain
cultiv
white
coloni
select
inocul
luriabertani
medium
supplement
g
kanamycin
per
ml
g
gentamicin
per
ml
g
tetracyclin
per
ml
grown
shake
rpm
isol
recombin
bacmid
perform
bac
bac
baculoviru
express
system
invitrogen
carlsbad
calif
accord
instruct
manufactur
bacmid
identifi
pcr
primer
pair
transfect
protein
express
analys
cell
transfect
recombin
bacmid
use
lipofectinmin
kit
invitrogen
accord
instruct
manual
provid
manufactur
h
posttransfect
cell
pellet
assay
protein
express
western
blot
assay
guinea
pig
antinucleocapsid
antispik
monospecif
serum
human
sarscovposit
serum
use
primari
antibodi
horseradish
peroxidas
hrp
conjug
goat
antiguinea
pig
antimous
immunoglobulin
ig
antihuman
igg
use
secondari
antibodi
membran
develop
use
tetrahydrochlorid
pierc
rockford
ill
substrat
protein
express
also
assess
newli
develop
ifa
describ
assay
use
primari
antibodi
use
western
blot
assay
fluorescein
isothiocyan
fitc
conjug
antibodi
secondari
antibodi
examin
fluoresc
stain
perform
fluoresc
microscop
identif
titrat
recombin
baculoviru
viral
dna
extract
viral
pellet
phenolchloroformisoamyl
alcohol
extract
viral
pellet
prepar
viruscontain
supernat
centrifug
g
h
viral
dna
use
templat
identif
recombin
baculoviru
pcr
puc
amplif
primer
cycl
condit
min
follow
cycl
min
hold
amplifi
product
eletrophores
agaros
determin
recombin
baculoviru
titer
accomplish
viral
plaqu
assay
briefli
ml
cell
grown
cellsml
dispens
well
sixwel
plate
plate
incub
room
temperatur
h
ensur
cell
attach
harvest
viral
supernat
dilut
eight
seri
dilut
inocul
supernat
remov
well
cell
inocul
dilut
viral
supernat
mixtur
incub
h
viru
inoculum
aspir
well
replac
ml
baculoviru
agaros
plate
incub
humidifi
incub
day
gray
plaqu
count
titer
calcul
follow
formula
pfu
origin
stock
factor
number
plaqu
millilit
inoculumwel
time
cours
studi
fusion
protein
express
western
blot
ifa
determin
time
level
protein
express
reach
peak
provid
clue
optim
time
immunofluoresc
antigen
prepar
cell
plate
simultan
infect
western
blot
assay
ifa
primari
antibodi
guinea
pig
antisc
serum
monoclon
antibodi
sixhi
tag
human
sarscovposit
serum
hrpor
fitcconjug
antibodi
use
secondari
antibodi
noninfect
cell
use
neg
control
develop
novel
ifa
h
infect
cell
express
fusion
protein
peak
level
select
develop
novel
ifa
cell
plate
fix
absolut
ethanol
min
room
temperatur
wash
three
time
phosphatebuff
salin
pb
ph
fix
cell
incub
antisc
serum
guinea
pig
serum
sarscovposit
human
serum
respect
h
well
wash
three
time
antigen
react
fitcconjug
antiguinea
pig
ig
dako
glostrup
denmark
fitcconjug
rabbit
antihuman
igg
igm
dako
appropri
anoth
three
wash
pb
cell
examin
stain
pattern
immunofluoresc
microscop
olympu
tokyo
japan
appropri
barrier
excit
filter
optim
visual
fitc
ifa
optim
sarscovposit
human
serum
sarscovneg
serum
serial
dilut
secondari
antibodi
fitcconjug
rabbit
antihuman
igg
igm
dilut
ifa
perform
describ
igg
igm
detect
optim
condit
defin
reaction
maximum
fluoresc
signal
observ
background
read
commerci
sarscov
ifa
kit
commerci
sarscov
ifa
kit
euroimmun
purchas
medizinisch
labordiagnostika
ag
gross
groenau
germani
kit
compos
biochip
slide
coat
sarscovinfect
cell
treat
disinfect
fix
agent
gamma
irradi
test
conduct
accord
instruct
manufactur
briefli
serum
sampl
dilut
sampl
buffer
provid
fig
recognit
guinea
pig
polyclon
antibodi
truncat
protein
nativ
nucleocapsid
protein
spike
protein
b
sarscovinfect
vero
cell
sarscovposit
human
serum
sampl
c
serv
posit
control
antiserum
sampl
sarscovinfect
vero
cell
c
mockinfect
cell
g
examin
fluoresc
microscop
reactiv
pattern
order
show
clearli
antisera
react
infect
cell
adjac
uninfect
cell
sidebysid
imag
field
view
light
microscop
f
immunofluoresc
microscop
c
kit
content
mix
vortex
twentyf
microlit
dilut
serum
sampl
appli
reaction
field
reagent
tray
biochip
slide
contain
chip
inactiv
sarscovinfect
vero
cell
alongsid
uninfect
cell
place
recess
reaction
tray
biochip
serum
sampl
allow
interact
min
room
temperatur
biochip
slide
rins
pbstween
least
min
l
fluoresceinlabel
antihuman
globulin
appli
reaction
chip
min
room
temperatur
slide
rins
glycerol
ad
coverslip
slide
place
face
forward
onto
prepar
coverslip
slide
view
invert
fluoresc
microscop
olympu
convent
ifa
convent
ifa
carri
laboratori
describ
previou
work
sarscov
propag
vero
cell
cytopath
effect
seen
cell
monolay
cell
harvest
spot
onto
teflonco
slide
fix
cold
aceton
uninfect
vero
cell
use
control
experi
serum
sampl
test
dilut
wash
pb
incub
either
min
follow
addit
fitcconjug
rabbit
antihuman
igm
min
follow
addit
fitcconjug
antihuman
igg
slide
incub
anoth
min
slide
subject
anoth
wash
cycl
read
specif
fluoresc
immunofluoresc
microscop
western
blot
purifi
truncat
protein
immunoblot
onto
nitrocellulos
membran
pore
size
biorad
serum
sampl
screen
dilut
follow
addit
peroxidaseconjug
secondari
antibodi
dako
accord
instruct
manufactur
tetrahydrochlorid
pierc
use
hrp
substrat
membran
develop
posit
neg
control
includ
test
sampl
consid
posit
specif
band
expect
size
observ
calcul
analysi
perform
novel
ifa
base
comparison
data
obtain
novel
ifa
obtain
commerci
ifa
convent
ifa
western
blot
establish
previou
work
sensit
specif
assay
calcul
use
follow
equat
sensit
number
sampl
trueposit
result
number
sampl
trueposit
result
number
sampl
falseneg
result
specif
number
sampl
trueneg
result
number
sampl
trueneg
result
number
sampl
falseposit
result
reactiv
polyclon
antibodi
recombin
nativ
protein
elisa
verifi
polyclon
antibodi
sc
protein
rais
guinea
pig
titer
antibodi
antibodi
sc
furthermor
antibodi
also
recogn
authent
n
spike
protein
assay
commerci
sarscov
ifa
kit
sarscovinfect
vero
cell
inactiv
serv
fluoresc
antigen
fluoresc
found
cytoplasm
antiserum
sc
protein
use
primari
antibodi
fig
b
antisera
shown
react
infect
cell
adjac
uninfect
cell
compar
field
light
microscop
fig
e
fluoresc
microscop
fig
b
nonspecif
fluoresc
observ
mockinfect
cell
fig
h
ifa
titer
antibodi
sc
protein
respect
commerci
sarscov
ifa
kit
ident
reactiv
pattern
found
two
polyclon
antisera
human
sarscovposit
serum
fig
f
tabl
data
demonstr
polyclon
antibodi
use
standard
posit
sera
protein
identif
process
develop
novel
ifa
construct
recombin
baculoviru
sc
gene
fragment
amplifi
rtpcr
follow
ligat
rapid
ligat
kit
roch
mannheim
germani
transform
cell
posit
coloni
harbor
fusion
gene
fragment
screen
follow
extract
recombin
plasmid
transposit
compet
cell
select
white
coloni
luriabertani
plate
contain
homolog
recombin
might
occur
smallscal
cultur
might
harbor
gene
interest
grown
bacmid
extract
bacmid
transfect
incub
day
viral
dna
isol
viral
pellet
identifi
pcr
fig
predict
size
kb
fragment
ns
fusion
gene
kb
plu
amplifi
product
pfastbacht
baculoviru
genom
protein
express
analys
express
respect
protein
confirm
western
blot
use
sarscovposit
human
serum
guinea
pig
serum
antisc
serum
primari
antibodi
fig
c
novel
ifa
fig
f
western
blot
demonstr
recombin
fusion
protein
express
cell
recogn
guinea
pig
antiserum
sc
protein
sarscovposit
human
serum
ifa
format
cell
infect
recombin
baculoviru
show
ident
fluoresc
signal
guinea
pig
antiserum
order
show
clearli
antisera
react
infect
cell
adjac
uninfect
cell
sidebysid
imag
field
view
light
microscop
g
immunofluoresc
microscop
f
sc
protein
well
sarscovposit
human
serum
use
primari
antibodi
fitcconjug
antibodi
use
secondari
antibodi
peak
level
express
also
determin
h
postinfect
data
shown
strongest
signal
posit
serum
sampl
weakest
signal
mockinfect
cell
obtain
time
immunofluoresc
sarscov
protein
express
cell
cell
infect
recombin
baculoviru
mockinfect
cell
incub
posit
control
sera
guinea
pig
antisc
serum
sarscovposit
human
serum
observ
fluoresc
light
microscop
observ
antisera
dilut
sc
dilut
react
infect
cell
adjac
uninfect
cell
immunofluoresc
stain
appear
granular
pattern
within
cytoplasm
show
ring
pattern
fluoresc
fig
f
guinea
pig
human
neg
control
sera
show
specif
stain
fluoresc
ring
pattern
ident
cell
antigen
stain
sarscovposit
human
serum
neither
sarscovneg
human
serum
normal
guinea
pig
serum
show
background
stain
recombin
baculovirusinfect
cell
also
true
concentr
guinea
pig
polyclon
antibodi
sc
mockinfect
cell
fig
l
crossreact
observ
cell
expos
anim
coronavirusinfect
sera
transmiss
gastroenter
viru
infecti
bronchiti
viru
canin
cat
coronavirus
result
show
specif
novel
ifa
reliabl
complet
agreement
result
obtain
recombin
baculovirus
contain
protein
fusion
protein
found
howev
basi
sensit
ifa
fusion
protein
gave
stronger
read
stronger
abil
detect
igm
antibodi
protein
alon
data
shown
addit
fusion
protein
found
present
solubl
form
observ
posit
signal
western
blot
indirect
elisa
supernat
sonic
infect
cell
use
antigen
solubl
properti
use
develop
elisa
therefor
recombin
baculoviru
express
fusion
protein
select
candid
use
experi
optim
novel
ifa
reveal
igg
igm
antibodi
detect
optim
work
dilut
serum
sampl
fitcconjug
rabbit
antihuman
igg
igm
dilut
dilut
respect
detect
sarscov
novel
ifa
analysi
novel
ifa
sensit
specif
novel
recombin
fusion
protein
ifa
assess
comparison
case
definit
clinic
confirm
sar
tabl
sarscovposit
serum
sampl
could
identifi
posit
serum
sampl
igg
antibodi
could
complet
detect
igm
antibodi
could
identifi
sampl
fifteen
sampl
confirm
posit
igg
igm
antibodi
novel
ifa
abl
identifi
sampl
sampl
antibodi
could
detect
western
blot
analysi
sampl
collect
day
onset
fever
overal
sampl
found
posit
give
sensit
novel
ifa
produc
falseposit
result
serum
sampl
healthi
peopl
serum
sampl
patient
autoimmun
diseas
thu
indic
specif
tabl
result
ifa
found
compar
convent
ifa
tabl
term
sensit
specif
ifa
sensit
western
blot
tabl
howev
one
sampl
collect
earli
stage
diseas
day
onset
test
neg
novel
ifa
well
three
method
sinc
outbreak
sar
global
effort
develop
rapid
accur
userfriendli
assay
earli
detect
sarscov
infect
diagnost
method
avail
present
includ
sequenc
detect
rtpcr
realtim
pcr
viru
isol
serolog
test
ifa
use
detect
specif
antibodi
produc
infect
consid
world
health
organ
gold
standard
detect
sarscov
infect
nevertheless
high
degre
pathogen
infect
sarscov
human
perform
viru
cultiv
restrict
laboratori
make
inconveni
hazard
antigen
product
safeti
issu
becom
even
paramount
import
two
recent
sar
case
singapor
taiwan
found
associ
inadequ
laboratori
safeti
procedur
lead
seriou
concern
possibl
live
sarscov
leakag
laboratori
could
becom
sourc
anoth
sar
outbreak
therefor
becom
extrem
import
investig
use
extra
precaut
handl
sarscov
prepar
antigen
procedur
perform
safer
manner
previou
work
identifi
immunogen
domain
sarscov
sc
protein
serum
antibodi
sarscov
could
react
effect
two
truncat
protein
particular
advantag
detect
igg
igm
antibodi
demonstr
western
blot
confirm
loyalti
fusion
protein
express
cell
suppos
use
novel
ifa
purifi
recombin
truncat
protein
sc
protein
express
e
coli
use
immun
guinea
pig
rais
polyclon
antibodi
two
protein
reactiv
two
antisera
fusion
protein
express
cell
total
cell
lysat
western
blot
infect
cellbas
ifa
techniqu
indic
success
express
target
sc
protein
furthermor
polyclon
antibodi
also
react
nativ
antigen
sarscovinfect
vero
cell
reaction
pattern
observ
fusion
proteinbas
ifa
wholevirusbas
ifa
show
baculovirusexpress
sc
protein
function
antigen
equal
authent
counterpart
sarscov
strongli
support
diagnost
potenti
fusion
protein
develop
new
assay
ifa
consid
gold
standard
detect
sarscov
infect
attempt
develop
similar
safer
detect
techniqu
elimin
need
use
laboratori
baculoviru
express
system
wide
appli
express
abund
heterolog
gene
cultur
insect
cell
case
recombin
protein
process
modifi
target
appropri
cellular
locat
function
like
nativ
counterpart
use
advantag
construct
recombin
baculovirus
express
protein
protein
infect
cell
recombin
baculovirus
develop
safer
ifa
sensit
ifa
compar
ifa
signific
differ
regard
igg
detect
observ
higher
level
igm
detect
stronger
posit
signal
observ
ifa
data
shown
moreov
fusion
protein
found
solubl
protein
thu
could
purifi
easili
impli
fusion
protein
also
potenti
use
develop
elisa
therefor
recom
time
cours
analys
western
blot
ifa
show
protein
express
cell
could
detect
prior
h
postinfect
weak
signal
express
protein
could
observ
h
postinfect
peak
level
protein
express
achiev
h
postinfect
time
could
detect
strongli
western
blot
ifa
signific
increment
protein
express
could
found
h
postinfect
addit
h
postinfect
cell
lyse
chang
morpholog
lead
higher
possibl
falseposit
result
result
unspecif
fluoresc
stain
also
report
ifa
detect
ebola
viru
infect
object
construct
fusion
protein
baculoviru
develop
ifa
increas
sensit
specif
diagnost
test
sarscov
fusion
proteinbas
ifa
abl
identifi
addit
posit
sampl
sar
patient
sampl
tabl
abl
detect
igm
antibodi
higher
rate
sarscovposit
serum
sampl
western
blot
sarscovposit
serum
sampl
support
primari
hypothesi
thu
accuraci
sensit
sarscov
detect
increas
novel
ifa
hand
ident
detect
rate
novel
ifa
commerci
wholevirusbas
ifa
kit
suggest
immunogen
enhanc
fusion
sc
protein
diagnost
abil
assay
fusion
protein
ident
assay
whole
viru
authent
antigen
commerci
ifa
kit
euroimmun
base
use
whole
sarscovinfect
vero
cell
treat
disinfect
fix
agent
gamma
irradi
thu
cell
still
maintain
authent
antigen
sarscov
howev
one
sampl
sampl
found
neg
four
test
could
explain
possibl
antibodi
absent
earli
stage
diseas
infect
individu
unabl
produc
antibodi
antigen
prepar
play
crucial
role
develop
diagnost
test
present
sarscov
elisa
antigen
prepar
deterg
extract
infect
vero
cell
subsequ
gamma
irradi
previou
work
develop
western
blot
assay
sensit
specif
howev
techniqu
timeconsum
technic
demand
involv
protein
express
purif
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
immunoblot
onto
nitrocellulos
membran
test
studi
fusion
protein
abundantli
express
recombin
baculoviru
cell
fixat
cell
could
use
directli
ifa
without
complic
procedur
protein
purif
ifa
variou
cell
includ
cell
express
recombin
nucleoprotein
develop
reduc
possibl
risk
infect
viru
escap
diagnost
test
process
highli
virul
pathogen
ebola
viru
crimeancongo
hemorrhag
fever
viru
influenza
viru
previou
report
diagnosi
sar
inactiv
sarscovinfect
vero
cell
use
antigen
develop
indirect
ifa
elisa
method
manipul
live
sarscov
biohazard
work
requir
laboratori
howev
novel
ifa
rate
antibodi
detect
complet
concord
two
avail
convent
ifa
could
carri
biosafeti
level
laboratori
lead
safer
easier
mean
antigen
prepar
ifa
exist
ifa
addit
cost
antigen
prepar
low
sinc
cell
cultur
easili
maintain
medium
without
fetal
bovin
serum
summari
develop
novel
ifa
sensit
specif
compar
wholevirusbas
ifa
addit
featur
safeti
costeffect
time
save
therefor
novel
ifa
may
offer
attract
altern
solut
current
test
involv
cultiv
sarscov
perform
laboratori
